PB-095Purity on request
CJC-1295 (DAC Modification)
C₁₅₂H₂₅₂N₄₄O₄₂
Long-acting, albumin-binding GHRH analog. DAC-modified 30-mer.
Research Use Only · Endocrine & Cell Repair Research Peptides
CAS 863288-34-0
Docs Documentation Available Upon Request
PB-107> 98% HPLC
Fig. · White to off-white powder
Endocrine & Cell Repair Research Peptides
Pasireotide
C₅₈H₆₆N₁₀O₉ · 1047.23 g/mol
Pasireotide is a synthetically stabilized cyclohexapeptide and next-generation somatostatin analog with broader SSTR-subtype engagement than first-generation analogs like octreotide and lanreotide. It is the API behind the approved drug Signifor and is supplied as a reference compound for somatostatin-receptor subtype-selectivity and neuroendocrine-signaling research.
Purity
> 98% HPLC
Quantity
Milligram, gram, or bulk quantities
Documentation
COA, HPLC, MS / LC-MS, SDS
Packaging
Bulk, non-branded, or private label
Research Use Only · Buyer verification required
Specifications
Technical profile.
Catalog Number
PB-107
CAS Number
396091-73-9
Sequence
cyclo[Tyr(Bzl)-Phe-Hyp(Bom)-Phg-D-Trp-Lys]
Molecular Formula
C₅₈H₆₆N₁₀O₉
Molecular Weight
1047.23 g/mol
Purity (HPLC)
> 98% (release specification)
Appearance
White to off-white powder
Vial Size
Confirmed with quotation
Storage
−20 °C, sealed, desiccated, protected from light
Reconstitution
DMSO (insoluble in water; formulated as L-aspartate or pamoate salt for parenteral use)
Classification
Research Use Only
Documentation & Quality
What documentation may be available for Pasireotide.
Pasireotide·PB-107
Certificate of Analysis (COA)
Manufacturing partner or independent summary of identity, purity, and other release testing for a batch.
Pending Verified Documentation
HPLC Chromatogram
Chromatographic data supporting the purity result reported for a batch.
Pending Verified Documentation
Mass Spectrometry (MS) Report
Mass spectrometry data supporting molecular identity confirmation.
Pending Verified Documentation
Endotoxin Test
Endotoxin testing result, where applicable to the product and its intended use.
Pending Verified Documentation
Safety Data Sheet (SDS)
Handling, storage, and safety information for the material.
Pending Verified Documentation
Third-Party Laboratory Report
Testing performed by an independent laboratory, separate from the manufacturing partner's own QC.
Pending Verified Documentation
Documentation is lot-specific. The statuses above describe what may be available, not a specific batch result. Lot-specific documentation is available with quotation or order. Please contact our team to confirm current documentation availability.
Request a QuoteRequest a Quote
Inquire about pricing and availability.
Bulk quantities, custom purity, documentation, and packaging options are reviewed for qualified business buyers.
Related compounds.
View full catalogPB-096Purity on request
Sermorelin
C₁₄₉H₂₄₆N₄₄O₄₂S
N-terminal 1–29 fragment of human GHRH. Shortest fully active form.
Research Use Only · Endocrine & Cell Repair Research Peptides
CAS 86168-78-7
Docs Documentation Available Upon Request
PB-097Purity on request
Tesamorelin
C₂₂₁H₃₆₆N₇₂O₆₇S
44-mer GHRH(1-44) analog with N-terminal hexenoyl cap.
Research Use Only · Endocrine & Cell Repair Research Peptides
CAS 218949-48-5
Docs Documentation Available Upon Request